Skip to content

Adjustable Strabismus Surgery

Adjustable Strabismus Surgery

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05425589
Enrollment
50
Registered
2022-06-21
Start date
2017-10-01
Completion date
2024-10-01
Last updated
2022-06-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Strabismus

Brief summary

Strabismus, whether congenital or acquired, is a common visual and cosmetic problem, especially for the young. Adjustable suture strabismus surgery is not in vogue in our country. This technique gives the surgeon a second attempt to provide a better outcome for the patients.

Interventions

Our objective was to assess the long-term success of adjustable suture strabismus surgery in terms of postoperative alignment and complications.

Sponsors

Foundation University Islamabad
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Prospective, interventional study

Eligibility

Sex/Gender
ALL
Age
5 Years to 69 Years
Healthy volunteers
Yes

Inclusion criteria

Horizontal, vertical and complex strabismus cases (sensory, paralytic, nystagmus, monocular elevation deficit and dissociated vertical/horizontal deviation) were included, along with patients with a previous history of strabismus surgery. Myasthenia gravis was excluded along with noncooperative children; less than 7 years of age. Those who did not return for a one year follow up also had to be excluded.

Design outcomes

Primary

MeasureTime frameDescription
Post-operative alignment1 yearThe post-operative alignment at 1 year will be measured and compared with the pre-operative alignment (deviation) to assess success rate.

Countries

Pakistan

Contacts

Primary ContactSana Nadeem, MBBS, FCPS, ACMEd
sana.nadeem@fui.edu.pk+92515788162

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026